Skip to content

uniQure QURE Business Segments — Royalty Financing Agreement Interest Expense

Similar metrics at other companies

Iovance Biotherapeutics, Inc. logo
IOVASingle Reportable — Royalty Expense
$2.65M+99.8%
Ocular Therapeutix logo
OCULSingle Reportable — Interest Expense Nonoperating
$2.78M-6.9%
Capricor Therapeutics logo
CAPRSingle Reportable — Interest Expense Nonoperating
$761.43K
BridgeBio Pharma logo
BBIOReportable Segment — Noncash interest expense on deferred royalty obligations
$39.87M+66.0%
Apple Hospitality logo
APLEReportable — Interest Income Expense Net
-$20.07M-3.5%
BioCryst Pharmaceuticals logo
BCRXNon-cash interest expense on royalty financing obligations
$13.29M-1.6%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept qure:RoyaltyFinancingAgreementInterestExpense.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's business segments — royalty financing agreement interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's business segments — royalty financing agreement interest expense?
uniQure (QURE) reported business segments — royalty financing agreement interest expense of $12.62M in Q1 2026.
How has uniQure's business segments — royalty financing agreement interest expense changed year-over-year?
uniQure's business segments — royalty financing agreement interest expense decreased by 5.2% year-over-year, from $13.31M to $12.62M.
What is the long-term trend for uniQure's business segments — royalty financing agreement interest expense?
Over 2 years (2023 to 2025), uniQure's business segments — royalty financing agreement interest expense has grown at a 41.7% compound annual growth rate (CAGR), from $26.93M to $54.1M.
What does business segments — royalty financing agreement interest expense mean?
Represents the cost of capital associated with financing arrangements where future royalty streams are pledged as collateral. This expense reflects the non-dilutive financing costs incurred to fund research and development activities. It is a vital metric for evaluating the company's long-term debt structure and future revenue commitments.